Nitric Oxide and Cyclic Guanosine Monophosphate Signaling Mediates the Antidepressant Effects of Acupuncture in the Rat Model of Chronic Unpredictable Mild Stress.
Acupuncture Points
Acupuncture Therapy
/ methods
Animals
Antidepressive Agents
/ therapeutic use
Behavior, Animal
/ drug effects
Cyclic GMP
/ metabolism
Depression
/ drug therapy
Depressive Disorder, Major
/ drug therapy
Disease Models, Animal
Guanosine Monophosphate
Hippocampus
/ metabolism
Male
Nitric Oxide
/ metabolism
Rats
Rats, Sprague-Dawley
Receptors, N-Methyl-D-Aspartate
/ metabolism
Signal Transduction
/ drug effects
Stress, Psychological
/ metabolism
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
30 Nov 2019
30 Nov 2019
Historique:
entrez:
1
12
2019
pubmed:
1
12
2019
medline:
22
5
2020
Statut:
epublish
Résumé
BACKGROUND Depression is a major mood disorder. Some patients have been reported to improve following acupuncture. This study aimed to investigate the effects of acupuncture on behaviors associated with depression in the chronic unpredictable mild stress (CUMS) rat model. The expression of signaling pathway components of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) in the rat hippocampus and plasma were also measured. MATERIAL AND METHODS Male Sprague-Dawley rats (N=40) were divided into the control group (N=10), the model group (N=10), the acupuncture group (N=10), and the non-acupuncture group (N=10). The rat model was established by orphaning combined with chronic unpredictable mild stress (CUMS) for six weeks. The acupuncture group was given 21 days of treatment using acupoints (AP) or non-acupoints (NP). Rat behaviors associated with depression were tested using the sucrose preference test (SPT), the open field test (OFT), and the elevated plus maze (EPM) test. Enzyme-linked immunoassay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR) were used to detect the expression of inducible nitric oxide synthase (iNOS), neuronal nitric oxide synthase (nNOS), and the N-methyl-D-aspartate (NMDA) receptor subunits, NR1, NR2A, and NR2B in the rat plasma and hippocampus. RESULTS Acupuncture reversed the behaviors associated with depression in the CUMS rat model and reduced the expression of components of the NO and cGMP pathway in the rat hippocampus and plasma. CONCLUSIONS In the CUMS rat model, treatment with acupuncture reduced behaviors associated with depression, and these effects were associated with changes in the NO and cGMP signaling pathway.
Identifiants
pubmed: 31785199
pii: 917593
doi: 10.12659/MSM.917593
pmc: PMC6900920
doi:
Substances chimiques
Antidepressive Agents
0
Receptors, N-Methyl-D-Aspartate
0
Nitric Oxide
31C4KY9ESH
Guanosine Monophosphate
85-32-5
Cyclic GMP
H2D2X058MU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9112-9122Références
Methods Mol Biol. 2019;1916:99-103
pubmed: 30535687
Zhen Ci Yan Jiu. 2009 Aug;34(4):236-41
pubmed: 19916286
J Neurochem. 2003 Jul;86(1):228-37
pubmed: 12807442
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:99-109
pubmed: 28396255
Am J Med. 2005 Dec 19;118 Suppl 12B:54-8
pubmed: 16414327
Neurosci Lett. 2016 Apr 8;618:31-38
pubmed: 26921452
BMJ Open. 2018 Dec 16;8(12):e026316
pubmed: 30559164
Handb Exp Pharmacol. 2019;250:287-305
pubmed: 30478734
Neurosci Lett. 2018 May 14;675:48-53
pubmed: 29601832
Am J Hosp Palliat Care. 2019 Apr;36(4):326-332
pubmed: 30286611
Front Psychiatry. 2018 Nov 06;9:561
pubmed: 30459657
Ann Intern Med. 2006 Jul 4;145(1):12-20
pubmed: 16818924
Nat Protoc. 2018 Jul;13(7):1686-1698
pubmed: 29988104
Neurosci Lett. 2016 Jan 26;612:52-61
pubmed: 26679225
Neurochem Res. 2018 Nov;43(11):2111-2120
pubmed: 30259256
J Neurosci. 2009 Jun 24;29(25):8225-35
pubmed: 19553462
J Clin Med. 2018 Oct 31;7(11):null
pubmed: 30384468
Bipolar Disord. 2004 Feb;6(1):75-81
pubmed: 14996144
Nat Neurosci. 2002 Nov;5 Suppl:1068-70
pubmed: 12403988
Int Clin Psychopharmacol. 2005 Sep;20(5):257-64
pubmed: 16096516
Neuron. 1997 Jun;18(6):1025-38
pubmed: 9208868
Brain Res. 2019 Feb 1;1704:114-126
pubmed: 30292770
Neurosci Lett. 2019 Jan 18;690:76-82
pubmed: 30315852
J Neurochem. 2006 Jun;97(6):1676-89
pubmed: 16805776
Evid Based Complement Alternat Med. 2017;2017:1676808
pubmed: 29098013
Medicine (Baltimore). 2019 Jan;98(2):e14073
pubmed: 30633212
Life Sci. 2018 Aug 1;206:117-124
pubmed: 29800538
Rheumatology (Oxford). 2008 Aug;47(8):1132-6
pubmed: 18460551
Front Psychiatry. 2018 Mar 27;9:102
pubmed: 29636708
Methods Mol Biol. 2019;1916:69-74
pubmed: 30535682
Transl Psychiatry. 2018 Sep 10;8(1):189
pubmed: 30202011